Nathan AS - Search Results

1

Racial, Ethnic, and Socioeconomic Disparities in Access to Transcatheter Aortic Valve Replacement Within Major Metropolitan Areas.

Nathan AS, Yang L, Yang N, Eberly LA, Khatana SAM, Dayoub EJ, Vemulapalli S, Julien H, Cohen DJ, Nallamothu BK, Baron SJ, Desai ND, Szeto WY, Herrmann HC, Groeneveld PW, Giri J, Fanaroff AC. Nathan AS, et al. JAMA Cardiol. 2022 Feb 1;7(2):150-157. doi: 10.1001/jamacardio.2021.4641. JAMA Cardiol. 2022. PMID: 34787635 Free PMC article.

2

Bioresorbable Scaffolds for Coronary Artery Disease.

Nathan A, Kobayashi T, Kolansky DM, Wilensky RL, Giri J. Nathan A, et al. Curr Cardiol Rep. 2017 Jan;19(1):5. doi: 10.1007/s11886-017-0812-7. Curr Cardiol Rep. 2017. PMID: 28108898 Review.

3

How Should We Address Carotid Artery Stenosis Around the Time of Open-Heart Surgery?

Giri J, Nathan A. Giri J, et al. JACC Cardiovasc Interv. 2017 Feb 13;10(3):299-301. doi: 10.1016/j.jcin.2016.12.018. JACC Cardiovasc Interv. 2017. PMID: 28183470 Free article. No abstract available.

4

Nitinol Self-Expanding Stents for the Superficial Femoral Artery.

Nathan A, Kobayashi T, Giri J. Nathan A, et al. Interv Cardiol Clin. 2017 Apr;6(2):227-233. doi: 10.1016/j.iccl.2016.12.006. Epub 2017 Jan 5. Interv Cardiol Clin. 2017. PMID: 28257770 Review.

5

Too Hot? Too Cold? When Is it "Just Right" to Stop Dual Antiplatelet Therapy After PCI With DES?

Giri J, Nathan A. Giri J, et al. JACC Cardiovasc Interv. 2017 Aug 28;10(16):1631-1632. doi: 10.1016/j.jcin.2017.07.004. JACC Cardiovasc Interv. 2017. PMID: 28838472 Free article. No abstract available.

6

Contemporary Antiplatelet Pharmacotherapy in the Management of Acute Coronary Syndromes.

Mangels DR, Nathan A, Tuteja S, Giri J, Kobayashi T. Mangels DR, et al. Curr Treat Options Cardiovasc Med. 2018 Feb 27;20(2):17. doi: 10.1007/s11936-018-0603-5. Curr Treat Options Cardiovasc Med. 2018. PMID: 29488032 Review.

7

Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation?

Giri J, Nathan A. Giri J, et al. JACC Cardiovasc Interv. 2018 Apr 9;11(7):635-637. doi: 10.1016/j.jcin.2017.12.002. Epub 2018 Mar 14. JACC Cardiovasc Interv. 2018. PMID: 29550087 Free article. No abstract available.

8

Prasugrel or Ticagrelor for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Does it Matter?

Giri J, Nathan A. Giri J, et al. JACC Cardiovasc Interv. 2018 Aug 27;11(16):1587-1589. doi: 10.1016/j.jcin.2018.04.047. Epub 2018 May 24. JACC Cardiovasc Interv. 2018. PMID: 29805110 Free article. No abstract available.

9

Association Between 30-Day Mortality After Percutaneous Coronary Intervention and Education and Certification Variables for New York State Interventional Cardiologists.

Khatana SAM, Fiorilli PN, Nathan AS, Kolansky DM, Mitra N, Groeneveld PW, Giri J. Khatana SAM, et al. Among authors: nathan as. Circ Cardiovasc Interv. 2018 Sep;11(9):e006094. doi: 10.1161/CIRCINTERVENTIONS.117.006094. Circ Cardiovasc Interv. 2018. PMID: 30354589 Free PMC article.

10

Use of Prasugrel and Ticagrelor in Stable Ischemic Heart Disease After Percutaneous Coronary Intervention, 2009-2016.

Dayoub EJ, Nathan AS, Khatana SAM, Seigerman M, Tuteja S, Kobayashi T, Kolansky DM, Groeneveld PW, Giri J. Dayoub EJ, et al. Among authors: nathan as. Circ Cardiovasc Interv. 2019 Jan;12(1):e007434. doi: 10.1161/CIRCINTERVENTIONS.118.007434. Circ Cardiovasc Interv. 2019. PMID: 30608869 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page